Literature DB >> 7121694

Methadone and heroin during pregnancy: a review of behavioral effects in human and animal offspring.

D E Hutchings.   

Abstract

Both clinical and animal studies indicate that prenatal exposure to opiate produces effects that occur in two phases. An acute phase consists of a neonatal abstinence syndrome characterized by increased CNS arousal. The major behavior symptoms seen in both humans and animals include hyperactivity, disturbed sleep and increased lability of state. This early phase can be quite prolonged, lasting from 12 weeks hyperactivity, disturbed sleep and increased lability of state. This early phase can be quite prolonged, lasting from 12 weeks to six months in humans and 20-25 days in rats. Although confirming pharmacokinetic studies are needed, it is possible that these persistent symptoms result from the slow clearance of the drug from neonatal tissues. The second phase of the syndrome is less well-understood but the available clinical evidence suggests that exposure to heroin, particularly in a pattern of polydrug abuse, can result in impaired organizational and perceptual abilities, poor self-adjustment and in situations requiring motor inhibition, heightened activity. Studies of pre-school children exposed prenatally to methadone, show no effects on intellectual and cognitive functioning but do reveal heightened activity or energy level, impulsivity, and brief attention span and persistence. A finding of impaired motor inhibition while performing a task has been stressed by one worker as an area of particular vulnerability among these children. A strikingly similar effect, characterized as an impaired ability to modulate task-oriented motor activity, has been described for adult rats prenatally exposed to methadone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7121694

Source DB:  PubMed          Journal:  Neurobehav Toxicol Teratol        ISSN: 0275-1380


  15 in total

1.  Sleep problems in children with prenatal substance exposure: the Maternal Lifestyle study.

Authors:  Kristen C Stone; Linda L LaGasse; Barry M Lester; Seetha Shankaran; Henrietta S Bada; Charles R Bauer; Jane A Hammond
Journal:  Arch Pediatr Adolesc Med       Date:  2010-05

Review 2.  Pregnancy and opiate addiction.

Authors:  P Caviston
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

Review 3.  Behavior and development patterns in children born to heroin-addicted and methadone-addicted mothers.

Authors:  S M Hayford; R P Epps; M Dahl-Regis
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

4.  Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation.

Authors:  K F Hauser; A A Houdi; C S Turbek; R P Elde; W Maxson
Journal:  Eur J Neurosci       Date:  2000-04       Impact factor: 3.386

Review 5.  Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing.

Authors:  Irving Zucker
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

6.  Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain.

Authors:  Emilse S Sanchez; John W Bigbee; Wambura Fobbs; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2008-07       Impact factor: 7.452

7.  Longitudinal study of maternal report of sleep problems in children with prenatal exposure to cocaine and other drugs.

Authors:  Kristen C Stone; Pamela C High; Cynthia L Miller-Loncar; Linda L Lagasse; Barry M Lester
Journal:  Behav Sleep Med       Date:  2009       Impact factor: 2.964

Review 8.  The impact of exposure to addictive drugs on future generations: Physiological and behavioral effects.

Authors:  F M Vassoler; E M Byrnes; R C Pierce
Journal:  Neuropharmacology       Date:  2013-06-25       Impact factor: 5.250

9.  Fetal assessment before and after dosing with buprenorphine or methadone.

Authors:  Amy L Salisbury; Mara G Coyle; Kevin E O'Grady; Sarah H Heil; Peter R Martin; Susan M Stine; Karol Kaltenbach; Manfred Weninger; Hendrée E Jones
Journal:  Addiction       Date:  2012-11       Impact factor: 6.526

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.